First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.
J Psychopharmacol – February 18, 2021
Source: PubMed
Summary
A groundbreaking investigation explored a novel therapeutic avenue for alcohol use disorder. Researchers hypothesized that combining psychotherapy with a unique compound could be a safe and tolerable treatment. Patients with alcohol use disorder participated, receiving the compound alongside therapy sessions. The findings revealed this integrated approach was generally well-tolerated and safe for participants, showing promising potential for future treatments.
Abstract
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.